Found 7 matching trials
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) PHASE2 The purpose of this study was to determine the appropriate dosing regimen o...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165) PHASE1 This study will assess the bioequivalence of single oral doses of aprepitan...
Show More Location
Multiple Locations
Learn More & Join Trial
Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting PHASE2 This study is aimed to evaluate the efficacy and safety of Fosrolapitant an...
Show More Location
Multiple Locations
Learn More & Join Trial
Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED) PHASE3 The study will test aprepitant for the prevention of CINV in patients recei...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134) PHASE1 This study will determine the appropriate dosing regimen of aprepitant and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017) PHASE3 The purpose of this study is to examine the safety, tolerability, and effic...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) PHASE3 This study aims to demonstrate that, when given concomitantly with a 5-hydr...
Show More Location
Multiple Locations
Learn More & Join Trial